Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab for Diffuse Diabetic Macular Edema
NCT00417716Phase 3Withdrawn
- Sponsor
- Asociación para Evitar la Ceguera en México
- Start
- Sep 2005
- Primary completion
- Sep 2005
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of bevacizumab in diabetic macular edema (DME), sponsored by Asociación para Evitar la Ceguera en México. Planned start Sep 2005; status: withdrawn.
02
Drugs
bevacizumab
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT00417716.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00417716.